content

Cannabis based medicines approved on NHS for first time

GW Pharmaceuticalsโ€™ Epidyolex and Sativex medicines were recommended by the National Institute for Health and Care Excellence (NICE) after being evaluated for their cost-effectiveness. Epidyolex...

A2 Biotherapeutics emerges from Stealth Mode to develop tumour cell therapeutics

A2 Biotherapeutics, a biotechnology company developing innovative cell therapies for cancer patients, announced its official launch. The company, founded in 2018 by veteran biotechnology...

CDMOs to benefit from rising BTDs, orphan drugs and fast track status

CPhI Worldwide โ€“ the worldโ€™s largest pharma event taking place in Frankfurt (5th โ€“ 7th November 2019) โ€“ has released the fourth part of...

Cold chain industry gathers in Mumbai for India Cold Chain Show 2019

India Cold Chain Show is an international event, which connects cold storage owners, end-users, service providers and logisticians. Taking place from 4-6 December 2019...

Anaqua Lands Patent Management Deal with the U.S. Army Medical Research and Development Command

Anaqua, the leading provider of innovation and intellectual property management solutions, announced that the U.S. Army Medical Research and Development Command (USAMRDC) has selected...

The increase in global demand for in vitro performance testing models for topical products

The most common way to deliver a drug is systemically via an oral tablet or injection. In many cases, delivery of a drug via...

Bioeq announces Coherus as marketing and distribution partner for its biosimilar to Lucentis in the U.S.

Zรผrich, Switzerland. Bioeq IP AG has announced that it signed a license and development agreement with Coherus BioSciences, Inc. , under which Coherus will...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read